Pharmacies - Southeast Asia

Southeast Asia

The Pharmacies market in Southeast Asia is anticipated to witness a substantial increase in revenue, with projections indicating that it will reach US$44.22bn by 2024.
Furthermore, it is expected to display a steady annual growth rate (CAGR 2024-2029) of 4.12%, resulting in a market volume of US$54.10bn by 2029.
When compared to the global market, United States is forecasted to generate the highest revenue, amounting to US$387.30bn in 2024.
In terms of per capita revenue, each person in Southeast Asia is expected to generate US$63.84 in 2024.
In Singapore, pharmacies are expanding their services to include wellness programs and health consultations to meet the growing demand for holistic healthcare.

Key regions: United States, China, Germany, Japan, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmacies market in Southeast Asia is experiencing significant growth and development. Customer preferences for convenience and accessibility, along with the increasing demand for healthcare products and services, are driving this trend. Additionally, local special circumstances and underlying macroeconomic factors are contributing to the expansion of the market. Customer preferences in Southeast Asia are shifting towards convenience and accessibility when it comes to purchasing healthcare products. With the rise of e-commerce and online platforms, consumers are increasingly turning to online pharmacies for their medication and healthcare needs. This allows them to easily compare prices, access a wide range of products, and have their orders delivered directly to their doorstep. Furthermore, the growing middle-class population in Southeast Asia is becoming more health-conscious and seeking out products that promote wellness and prevention. As a result, pharmacies are expanding their offerings to include vitamins, supplements, and other health-related products to cater to these customer preferences. Trends in the market are also being influenced by local special circumstances in Southeast Asia. For example, the region has a high prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory illnesses. This has led to an increased demand for medication and healthcare services, driving the growth of pharmacies. Additionally, the aging population in Southeast Asia is also contributing to the expansion of the market. As people live longer, there is a greater need for medication and healthcare products to manage age-related conditions and improve quality of life. Underlying macroeconomic factors are also playing a role in the development of the Pharmacies market in Southeast Asia. The region has been experiencing rapid economic growth, leading to higher disposable incomes and increased healthcare spending. As a result, consumers are willing to spend more on healthcare products and services, including prescription medication and over-the-counter drugs. Furthermore, government initiatives to improve access to healthcare and promote wellness are also driving the growth of the market. Southeast Asian governments are investing in healthcare infrastructure and implementing policies to ensure affordable and accessible healthcare for their citizens. In conclusion, the Pharmacies market in Southeast Asia is experiencing growth and development due to customer preferences for convenience and accessibility, increasing demand for healthcare products, local special circumstances, and underlying macroeconomic factors. As the region continues to see economic growth and an aging population, the demand for medication and healthcare services is expected to further drive the expansion of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.